Engineered Virus and Immunotherapy: New Hope for Glioblastoma Brain Cancer Patients
LINK IN BIO
A new study details the safe and promising use of an engineered oncolytic virus (DNX-2401) alongside immunotherapy in treating recurrent glioblastoma (GBM).
Despite not meeting its primary efficacy endpoi…
Keep reading with a 7-day free trial
Subscribe to Dr José Nasser MD PHD Substack to keep reading this post and get 7 days of free access to the full post archives.